Abstract
Prospective Evaluation of Allogeneic HSCT at the First Remission for Younger Adults with FLT3-ITD Positive Acute Myeloid Leukemia: The JALSG AML209-FLT3-SCT Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have